title: Reproductive choices for women with HIV.
abstract: Access to reproductive health services for women with HIV is critical to ensuring their reproductive needs are addressed and their reproductive rights are protected. In addition, preventing unintended pregnancies in women with HIV is an essential component of a comprehensive prevention of mother-to-child transmission (PMTCT) programme. As a result, a call for stronger linkages between sexual and reproductive health and HIV policies, programmes and services has been issued by several international organizations. However, implementers of PMTCT and other HIV programmes have been constrained in translating these goals into practice. The obstacles include: (i) the narrow focus of current PMTCT programmes on treating HIV-positive women who are already pregnant; (ii) separate, parallel funding mechanisms for sexual and reproductive health and HIV programmes; (iii) political resistance from major HIV funders and policy-makers to include sexual and reproductive health as an important HIV programme component; and (iv) gaps in the evidence base regarding effective approaches for integrating sexual and reproductive health and HIV services. However, we now have a new opportunity to address these essential linkages. More supportive political views in the United States of America and the emergence of health systems strengthening as a priority global health initiative provide important springboards for advancing the agenda on linkages between sexual and reproductive health and HIV. By tapping into these platforms for advocating and by continuing to invest in research to identify integrated service delivery best practices, we have an opportunity to strengthen ties between the two synergistic fields.
authors.affiliation: Family Health International, Research Triangle Park, NC 27709, USA. rwilcher@fhi.org
authors.forename: Rose
authors.initials: R
authors.lastname: Wilcher
authors.forename: Willard
authors.initials: W
authors.lastname: Cates
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D005260:Female; D005381:Financing, Organized; D015658:HIV Infections / Q000635:transmission*; D006266:Health Education / Q000458:organization & administration; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011057:Politics; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000517:prevention & control; D049168:Pregnancy, Unplanned; D034121:Reproductive Health Services / Q000458:organization & administration*; D018511:Systems Integration; D016387:Women's Health
chemical_list: D044966:Anti-Retroviral Agents